Andhra HC holds ruling in Ranbaxy-Sun Pharma case

Tags: News
The Andhra Pradesh High Court will announce its decision on Saturday on the plea of two investors requesting it to restrain BSE and NSE from giving any clearance to the $3.2 billion Sun Pharma-Ranbaxy merger.

After hearing the case, following the Supreme Court’s direction on Wednesday, the court reserved the order for Saturday. The court had earlier issued interim orders to maintain status quo with regard to the merger.

The petitioners at the end of April had raised objections over the heavy trading of Ranbaxy share before the announcement of acquisition of Ranbaxy by Sun Pharma. The court had also asked other parties like Daichii Sankyo and Silver Street developers not to go ahead with the process.

Justice G Chandraiah heard arguments on behalf of petitioners as well as Sun Pharma, Ranbaxy and Sebi. The market regulator informed the court that an investigation was on regarding insider trading as Ranbaxy shares jumped over 20 per cent, a week before the deal was announced.

The Ranbaxy counsel said merger should not be stopped, as insider trading and merger were two different things and could not be looked from the same angle. “The petitioners have no locus standi to file the petition to restrain the merger citing insider trading as they bought shares after the announcement," said D Prakash Reddy, counsel for Ranbaxy.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • If the first 17 editions of Saarc were tragedies, Kathmandu was a sham

    Rarely has a regional grouping such as the South Asian Association of Regional Cooperation (Saarc) promised so much and delivered so little.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: Future in your hands

A common reference point as to why people believe the ...

Zehra Naqvi

Being unrealistic can be good for you

Depression is a term that most people use very casually ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture